Variant report

Variant	rs11810305
Chromosome Location	chr1:161704111-161704112
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr1:161703503..161707776-chr1:161717836..161724077,7	K562	blood:
2	chr1:161702286..161705058-chr1:161705873..161710501,6	K562	blood:

Variant related genes	Relation type
ENSG00000081721	Chromatin interaction

Extended variants
information (count: 9 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:5)

rs_ID	r²[population]
rs1503812	0.98[ASN][1000 genomes]
rs1503813	0.83[AFR][1000 genomes];0.98[AMR][1000 genomes];0.99[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs2840310	0.98[ASN][1000 genomes]
rs6698889	0.87[ASN][1000 genomes]
rs905589	0.98[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:4 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv428257	chr1:161406315-161868263	Bivalent/Poised TSS Genic enhancers Active TSS Transcr. at gene 5' and 3' Enhancers Weak transcription Bivalent Enhancer Strong transcription Flanking Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	50 gene(s)	inside rSNPs	diseases
2	esv33393	chr1:161478681-162080327	Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Active TSS Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	59 gene(s)	inside rSNPs	diseases
3	nsv464184	chr1:161646807-161885352	Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Strong transcription Bivalent Enhancer Genic enhancers Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	36 gene(s)	inside rSNPs	diseases
4	nsv548075	chr1:161646807-161885352	Weak transcription Strong transcription Enhancers ZNF genes & repeats Active TSS Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	36 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:37 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr1:161697800-161706600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
2	chr1:161698000-161706000	Enhancers	NHEK	skin
3	chr1:161698000-161707600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
4	chr1:161698400-161704400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
5	chr1:161698600-161705600	Weak transcription	A549	lung
6	chr1:161699200-161704400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
7	chr1:161699200-161707400	Enhancers	HMEC	breast
8	chr1:161700200-161707800	Weak transcription	Primary B cells from peripheral blood	blood
9	chr1:161700200-161708400	Weak transcription	Primary T helper naive cells from peripheral blood	blood
10	chr1:161700600-161705400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
11	chr1:161700600-161705600	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
12	chr1:161700600-161706000	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
13	chr1:161700600-161706200	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
14	chr1:161700800-161705000	Weak transcription	GM12878-XiMat	blood
15	chr1:161700800-161705600	Weak transcription	iPS-20b Cell Line	embryonic stem cell
16	chr1:161700800-161706000	Weak transcription	Hela-S3	cervix
17	chr1:161701000-161706000	Weak transcription	H9 Cell Line	embryonic stem cell
18	chr1:161701400-161706000	Weak transcription	HUES48 Cell Line	embryonic stem cell
19	chr1:161701800-161705600	Weak transcription	HUES6 Cell Line	embryonic stem cell
20	chr1:161702600-161704400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
21	chr1:161702600-161704400	Enhancers	Muscle Satellite Cultured Cells	--
22	chr1:161702600-161704600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
23	chr1:161702600-161704600	Enhancers	NHDF-Ad	bronchial
24	chr1:161702800-161704200	Enhancers	Osteobl	bone
25	chr1:161703400-161704200	Weak transcription	HSMMtube	muscle
26	chr1:161703400-161704400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
27	chr1:161703400-161706000	Weak transcription	K562	blood
28	chr1:161703800-161704200	Enhancers	Placenta	Placenta
29	chr1:161704000-161704200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
30	chr1:161704000-161704200	Enhancers	Breast Myoepithelial Primary Cells	Breast
31	chr1:161704000-161706000	Weak transcription	NH-A	brain
32	chr1:161704000-161706200	Weak transcription	HSMM	muscle
33	chr1:161704000-161706400	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
34	chr1:161704000-161706400	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
35	chr1:161704000-161706400	Weak transcription	NHLF	lung
36	chr1:161704000-161708600	Weak transcription	Primary hematopoietic stem cells short term culture	blood
37	chr1:161704000-161713800	Weak transcription	HUVEC	blood vessel

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links